Author Archives: donttradeourlivesaway

Lawmaker: Costly hepatitis C drug “a slap in the face to the veterans”

CBS NEWS| February 3, 2016 A Congressional hearing will begin Wednesday in response to a CBS News investigation that showed how a costly new cure for hepatitis C isn’t making it to most of the 200,000 U.S. veterans infected with … Continue reading

Posted in Hepatitis C, Uncategorized | Leave a comment

Why is Gilead charging VA $40,000 for drug?

Jeff Miller, CNN| January 27, 2016 In America, honoring our veterans comes second nature to most citizens. That’s because the overwhelming majority of our people understand that, if not for the service and sacrifice of those who have worn the uniform, … Continue reading

Posted in Hepatitis C, Sofosbuvir, Uncategorized | Leave a comment

UN Expert Urges TPP Countries Not to Sign the TPP Without Committing to Human Rights and Development

TWN| Feb 2, 2016 GENEVA (2 February 2016) – United Nations human rights expert Alfred de Zayas called on Governments not to sign the Trans-Pacific Partnership (TPP) without reaffirming their human rights treaty obligations and their recent pledges to achieve … Continue reading

Posted in TPP, Uncategorized | Leave a comment

India-EU FTA talks’ revival likely to be delayed

Deal’s fate rests on ‘talks about talks’ between senior officials as EU demands greater flexibility on imports Asit Ranjan Mishra|Live Mint|Wed, Feb 03 2016. 01 45 AM IST New Delhi: Demands for India to show more flexibility in the import … Continue reading

Posted in EU-India FTA, Uncategorized | Leave a comment

President of Ukraine submits bill to parliament on changes to TRIPS agreement as for compulsory licensing mechanisms

Interfax-Ukraine|Jan 23, 2016 President of Ukraine Petro Poroshenko has registered in the Verkhovna Rada a bill on adopting the protocol on amendments to the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (the TRIPS Agreement) with respect to flexible … Continue reading

Posted in Compulsory Licensing, TRIPS flexibilities, Uncategorized, WTO | Leave a comment

NIH urged to ‘break taboo’ against using its power to bypass drug patents

Organizations echo Congress in demanding ‘march-in’ action from feds By Emily Wasserman, FiercePharma|January 14, 2016   The National Institutes of Health (NIH) has said that it would take “extraordinary” circumstances to use its little-known power to bypass certain drug patents. … Continue reading

Posted in Bayh Dole Act, Compulsory Licensing, Right to Health, Uncategorized | Leave a comment

Cuomo enters national debate with proposal to cap drug prices

By DAN GOLDBERG | PoliticoNewYork|Jan. 20, 2016 Gov. Andrew Cuomo is seeking effectively to cap the price of certain pharmaceuticals and require unprecedented transparency from manufacturers. The governor’s new budget proposals, which are opposed by pharmaceutical companies, inject the governor … Continue reading

Posted in Pricing, Uncategorized | Leave a comment